The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Regulatory and Safety Considerations in Deploying a Locally Fabricated, Reusable Face Shield in a Hospital Responding to the COVID-19 Pandemic

    1. Arash Mostaghimi
    2. Marc-Joseph Antonini
    3. Deborah Plana
    4. Philip D. Anderson
    5. Brandon Beller
    6. Edward W. Boyer
    7. Amber Fannin
    8. Jacob Freake
    9. Richard Oakley
    10. Michael S. Sinha
    11. Leanne Smith
    12. Christopher Van
    13. Helen Yang
    14. Peter K. Sorger
    15. Nicole R. LeBoeuf
    16. Sherry H. Yu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. The clinical characteristics and mortal causes analysis of COVID-19 death patients

    1. Ao-Xiang Guo
    2. Jia-Jia Cui
    3. Qian-Ying OuYang
    4. Li He
    5. Cheng-Xian Guo
    6. Ji-Ye Yin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity

    1. Jeffrey S. Smith
    2. Haley Hanseler
    3. John Welle
    4. Rogan Rattray
    5. Mary Campbell
    6. Tacy Brotherton
    7. Tarsem Moudgil
    8. Thomas F. Pack
    9. Keith Wegmann
    10. Shawn Jensen
    11. Justin Jin
    12. Carlo B. Bifulco
    13. Scott A. Prahl
    14. Bernard A. Fox
    15. Nicholas L. Stucky

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Epidemiological investigation and intergenerational clinical characteristics of 24 coronavirus disease patients associated with a supermarket cluster: a retrospective study

    1. Suochen Tian
    2. Min Wu
    3. Zhenqin Chang
    4. Yunxia Wang
    5. Guijie Zhou
    6. Wenming Zhang
    7. Junmin Xing
    8. Hui Tian
    9. Xihong Zhang
    10. Xiuli Zou
    11. Lina Zhang
    12. Mingxin Liu
    13. Juan Chen
    14. Jian Han
    15. Kang Ning
    16. Shuangfeng Chen
    17. Tiejun Wu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Human agency and infection rates: Implications for social distancing during epidemics

    1. Christopher Bronk Ramsey

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Modeling COVID‐19: Forecasting and analyzing the dynamics of the outbreaks in Hubei and Turkey

    1. Ibrahim Halil Aslan
    2. Mahir Demir
    3. Michael Morgan Wise
    4. Suzanne Lenhart

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Multidrug treatment with nelfinavir and cepharanthine against COVID-19

    1. Hirofumi Ohashi
    2. Koichi Watashi
    3. Wakana Saso
    4. Kaho Shionoya
    5. Shoya Iwanami
    6. Takatsugu Hirokawa
    7. Tsuyoshi Shirai
    8. Shigehiko Kanaya
    9. Yusuke Ito
    10. Kwang Su Kim
    11. Kazane Nishioka
    12. Shuji Ando
    13. Keisuke Ejima
    14. Yoshiki Koizumi
    15. Tomohiro Tanaka
    16. Shin Aoki
    17. Kouji Kuramochi
    18. Tadaki Suzuki
    19. Katsumi Maenaka
    20. Tetsuro Matano
    21. Masamichi Muramatsu
    22. Masayuki Saijo
    23. Kazuyuki Aihara
    24. Shingo Iwami
    25. Makoto Takeda
    26. Jane A. McKeating
    27. Takaji Wakita

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

    1. Brandi N. Williamson
    2. Friederike Feldmann
    3. Benjamin Schwarz
    4. Kimberly Meade-White
    5. Danielle P. Porter
    6. Jonathan Schulz
    7. Neeltje van Doremalen
    8. Ian Leighton
    9. Claude Kwe Yinda
    10. Lizzette Pérez-Pérez
    11. Atsushi Okumura
    12. Jamie Lovaglio
    13. Patrick W. Hanley
    14. Greg Saturday
    15. Catharine M. Bosio
    16. Sarah Anzick
    17. Kent Barbian
    18. Tomas Cihlar
    19. Craig Martens
    20. Dana P. Scott
    21. Vincent J. Munster
    22. Emmie de Wit

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets

    1. Dorothea Bestle
    2. Miriam Ruth Heindl
    3. Hannah Limburg
    4. Thuy Van Lam van
    5. Oliver Pilgram
    6. Hong Moulton
    7. David A. Stein
    8. Kornelia Hardes
    9. Markus Eickmann
    10. Olga Dolnik
    11. Cornelius Rohde
    12. Stephan Becker
    13. Hans-Dieter Klenk
    14. Wolfgang Garten
    15. Torsten Steinmetzer
    16. Eva Böttcher-Friebertshäuser

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics

    1. Nils C. Gassen
    2. Jan Papies
    3. Thomas Bajaj
    4. Frederik Dethloff
    5. Jackson Emanuel
    6. Katja Weckmann
    7. Daniel E. Heinz
    8. Nicolas Heinemann
    9. Martina Lennarz
    10. Anja Richter
    11. Daniela Niemeyer
    12. Victor M. Corman
    13. Patrick Giavalisco
    14. Christian Drosten
    15. Marcel A. Müller

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 338 of 2361 Older